Xylem Inc. $XYL Shares Acquired by Vanguard Personalized Indexing Management LLC

Vanguard Personalized Indexing Management LLC raised its holdings in Xylem Inc. (NYSE:XYLFree Report) by 19.0% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 56,216 shares of the industrial products company’s stock after acquiring an additional 8,960 shares during the quarter. Vanguard Personalized Indexing Management LLC’s holdings in Xylem were worth $8,292,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also made changes to their positions in XYL. AEGON ASSET MANAGEMENT UK Plc boosted its holdings in Xylem by 9.8% during the third quarter. AEGON ASSET MANAGEMENT UK Plc now owns 417,651 shares of the industrial products company’s stock worth $61,629,000 after buying an additional 37,189 shares in the last quarter. Intact Investment Management Inc. acquired a new stake in Xylem during the third quarter valued at $1,224,000. LBP AM SA increased its holdings in Xylem by 0.6% in the third quarter. LBP AM SA now owns 282,484 shares of the industrial products company’s stock worth $41,666,000 after buying an additional 1,550 shares during the last quarter. Cullen Frost Bankers Inc. raised its position in Xylem by 8.7% during the third quarter. Cullen Frost Bankers Inc. now owns 4,093 shares of the industrial products company’s stock valued at $604,000 after acquiring an additional 327 shares in the last quarter. Finally, Whittier Trust Co. raised its position in Xylem by 1.1% during the third quarter. Whittier Trust Co. now owns 10,930 shares of the industrial products company’s stock valued at $1,638,000 after acquiring an additional 117 shares in the last quarter. 87.96% of the stock is currently owned by institutional investors.

Xylem Trading Up 1.5%

Shares of Xylem stock opened at $143.38 on Tuesday. Xylem Inc. has a 1 year low of $100.47 and a 1 year high of $154.27. The company has a market cap of $34.91 billion, a price-to-earnings ratio of 36.86, a PEG ratio of 2.00 and a beta of 1.17. The company’s fifty day simple moving average is $139.71 and its 200-day simple moving average is $141.69. The company has a current ratio of 1.96, a quick ratio of 1.50 and a debt-to-equity ratio of 0.17.

Xylem (NYSE:XYLGet Free Report) last announced its quarterly earnings data on Tuesday, October 28th. The industrial products company reported $1.37 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.23 by $0.14. The company had revenue of $2.27 billion during the quarter, compared to analysts’ expectations of $2.22 billion. Xylem had a net margin of 10.66% and a return on equity of 10.77%. The business’s revenue was up 7.8% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.11 EPS. As a group, sell-side analysts expect that Xylem Inc. will post 4.65 EPS for the current year.

Xylem Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, December 23rd. Shareholders of record on Tuesday, November 25th were given a $0.40 dividend. The ex-dividend date was Tuesday, November 25th. This represents a $1.60 dividend on an annualized basis and a yield of 1.1%. Xylem’s payout ratio is 41.13%.

Analyst Upgrades and Downgrades

Several analysts have commented on the stock. Barclays decreased their target price on shares of Xylem from $172.00 to $166.00 and set an “overweight” rating for the company in a research report on Wednesday, January 7th. Weiss Ratings reissued a “buy (b-)” rating on shares of Xylem in a research report on Monday, December 29th. Wall Street Zen lowered Xylem from a “buy” rating to a “hold” rating in a report on Saturday, December 27th. Robert W. Baird set a $178.00 price target on Xylem in a research note on Wednesday, October 29th. Finally, William Blair started coverage on Xylem in a report on Monday. They set an “outperform” rating on the stock. Nine investment analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. According to data from MarketBeat.com, Xylem currently has a consensus rating of “Moderate Buy” and a consensus target price of $165.80.

View Our Latest Research Report on XYL

Insider Activity

In other Xylem news, Director Victoria D. Harker sold 1,700 shares of Xylem stock in a transaction on Tuesday, November 4th. The stock was sold at an average price of $148.14, for a total value of $251,838.00. Following the completion of the transaction, the director owned 16,875 shares in the company, valued at approximately $2,499,862.50. The trade was a 9.15% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, EVP Claudia S. Toussaint sold 10,421 shares of Xylem stock in a transaction dated Thursday, October 30th. The shares were sold at an average price of $152.64, for a total value of $1,590,661.44. Following the completion of the transaction, the executive vice president directly owned 31,250 shares of the company’s stock, valued at $4,770,000. This represents a 25.01% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 0.27% of the stock is currently owned by corporate insiders.

About Xylem

(Free Report)

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.

See Also

Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYLFree Report).

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.